Chemed Corporation (CHE)

Healthcare · NYQ

$509.03-0.59% today

Price as at 30 Sept 2026, 17:00 UTC. Quotes are delayed.

Fundamentals

Market cap$6.53B
P/E ratio26.7
Dividend yield0.49%
Revenue growth (YoY)+1.6%
Profit margin10.2%
Return on equity25.6%
52-week range$365.21 to $557.00

Valuation and ratings

Fair value estimate$196.91
Upside to fair value-61.3%
Analyst target (mean)$474.00
Analyst range$436.00 to $510.00
Analysts with price targets4
Consensus viewbuy
Moat score53/100
Overall rating32/100, low quality

Fair value: $196.91 (-61.3%), see how we got there

Chemed Corporation trades at $509.03, which is 61% above the $196.91 our fair value estimate puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.

Our moat model scores it 53 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

It changes hands at 26.7 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.

CHE dividend history

Dividend yield0.49%
Paid, trailing 12 months$2.50 per share
Most recent payment$0.700, ex 17 Aug 2026
5-year growth (p.a.)+10.8%
Consecutive years of growth17
Consecutive years paid38

Dividends per share by year

YearTotal per sharePayments
2026 (year to date)$1.903
2025$2.204
2024$1.804
2023$1.564
2022$1.484
2021$1.404
2020$1.324
2019$1.244
2018$1.164
2017$1.084
2016$1.004

Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.

CHE earnings and analyst estimates

EPS estimate, next year$26.88
Expected EPS growth+10.4%
Expected revenue growth+6.2%

Recommendation mix, 4 published ratings

1 buy3 hold0 sell

Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.

About Chemed Corporation

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Industry: Medical Care FacilitiesEmployees: 15,811HQ: United States

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

CHE passes 2 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

Super investor ownership

13 of the funds we track reported a position in their latest SEC 13F filing. Largest first:

A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.

Politician trades in CHE

We hold 6 disclosed trades in CHE by members of Congress and executive-branch officials. The latest 5:

  • Byron Donalds · HouseSell · $1,001 - $15,000 · traded 6 Mar 2025 · disclosed 14 Apr 2025
  • Byron Donalds · HouseSell · $1,001 - $15,000 · traded 6 Mar 2025 · disclosed 14 Apr 2025
  • Daniel Goldman · HouseSell · $1,001 - $15,000 · traded 31 Jan 2023 · disclosed 24 Feb 2023
  • Greg Gianforte · HouseSell · $1,001 - $15,000 · traded 13 Oct 2020 · disclosed 9 Nov 2020
  • Donna Shalala · HouseSell · $1,001 - $15,000 · traded 24 Jun 2019 · disclosed 27 Apr 2020

A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.

CHE peers

The largest companies in the same industry (Medical Care Facilities), then in the same sector.

Every healthcare company we cover is on the Healthcare hub.

Common questions

Is Chemed Corporation (CHE) undervalued?

Against our fair value estimate of $196.91, CHE at $509.03 is 61% above fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.

Which funds own CHE?

13 of the institutions we track reported a position in CHE in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.

What is CHE's P/E ratio?

CHE trades at 26.7 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.

Does Chemed Corporation (CHE) pay a dividend?

Yes. Chemed Corporation yields 0.49% at the current share price. It has paid $2.50 per share over the trailing twelve months. It has paid a dividend in each of the last 38 complete calendar years. A dividend is declared by the board and can be cut at any time; a yield is a fact about the current price, not a promise.

Where does SteadyShares get its CHE data?

Fundamentals for CHE come from company filings and exchange data, as listed on NYQ; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 17:00 UTC and is delayed. Our data quality score for this company is 100/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for CHE, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.